Clarithromycin/Pomalidomide/Dexamethasone for Relapsed/Refractory MM


Clarithromycin/Pomalidomide/Dexamethasone for Relapsed/Refractory MM
Slides from a presentation at ASH 2012 and transcribed comments from a recent interview with A Keith Stewart, MBChB (1/9/13)
Mark TM et al. ClaPD (clarithromycin, pomalidomide, dexamethasone) therapy in relapsed or refractory multiple myeloma. Proc ASH 2012;Abstract 77.

Dr Stewart is Dean for Research at the Mayo Clinic in Arizona, is Consultant in the Division of Hematology/Oncology and holds the Vasek and Anna Maria Polak Professorship in Cancer Research in Scottsdale, Arizona.